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Abstract—We present an interpretable neural network for
predicting an important clinical outcome (1-year mortality) from
multi-modal Electronic Health Record (EHR) data. Our ap-
proach builds on prior multi-modal machine learning models by
now enabling visualization of how individual factors contribute to
the overall outcome risk, assuming other factors remain constant,
which was previously impossible.
We demonstrate the value of this approach using a large
multi-modal clinical dataset including both EHR data and 31,278
echocardiographic videos of the heart from 26,793 patients. We
generated separate models for (i) clinical data only (CD) (e.g.
age, sex, diagnoses and laboratory values), (ii) numeric variables
derived from the videos, which we call echocardiography-derived
measures (EDM), and (iii) CD+EDM+raw videos (pixel data).
The interpretable multi-modal model maintained performance
compared to non-interpretable models (Random Forest, XG-
Boost), and also performed significantly better than a model
using a single modality (average AUC=0.82). Clinically relevant
insights and multi-modal variable importance rankings were
also facilitated by the new model, which have previously been
impossible.
I. INTRODUCTION
The adoption of Electronic Health Records (EHR) in
medicine has facilitated the collection of massive amounts of
clinical data which can be used to develop highly accurate
risk models that physicians can use to guide medical decision
making. To take full advantage of the available EHR data,
these models, similar to a physician, need to be able to handle
multiple modalities as inputs. For example, both tabular data
such as laboratory measurements and pixel data from clinical
images should be readily incorporated. This basic framework
is shown in Fig. 1.
As documented in [1], [2], [3], [4], precision medicine
can benefit greatly from development of these risk models.
The proliferation of these models has prompted scrutiny from
the medical community, which demands clinical validity and
interpretability to improve usefulness [5] and inclusion of all
relevant predictors (or, conversely, explanation when a relevant
data input is excluded) [6]. Moreover, the recent European
General Data Protection Regulation (https://eugdpr.org/) states
that individuals who have decisions made about them by
algorithms have a right to know the basis of the decision and
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the factors that influenced this decision. Thus, any medical risk
model should be interpretable and facilitate understanding of
the various contributions of different inputs towards the overall
risk assessment.
When only using tabular EHR data, clinical interpretability
is well supported by linear models. To see this, note that the
coefficients of the different predictors can be used to assess
feature importance based on the magnitude of each coefficient,
and effect directionality based on the sign. Unfortunately, the
performance of linear models can be limited. As described in
[1], for predicting mortality risk using EHR data, non-linear
models such as random forests outperform linear models.
While not as direct as for linear models, there are also
approaches to support clinical interpretability for non-linear
methods. As an example, for ensemble methods based on
decision trees (e.g., Random Forests), we can rank the input
features based on the proportion of samples that appear at each
decision node where each feature is used. Unfortunately, there
is no direct explanation for the input effect. Currently, methods
to support clinical interpretability include building a single tree
with multivariate decision nodes [7], extracting an optimal
tree with a minimum performance cost [8], and an indirect
method that offers recommendations for transforming true
negative instances into positively predicted ones [9]. However,
the ability to expand such interpretable models to more robust,
multi-modal frameworks—capable of ingesting all the diverse
and heterogeneous elements of EHR data, such as digital
images and videos—has been challenging. To date, no such
model has been developed.
A major challenge in developing interpretable multi-modal
models for clinical use is that non-interpretable deep learning
methods dominate research on data such as medical images
[10] and tabular EHR data [11]. To particularly highlight the
capabilities of deep learning in medical imaging analysis, such
methods have been used in ultrasound video analysis for frame
labeling tasks such as segmentation of certain chambers of
the heart (the left ventricle) [12], [13], fetal standard image
plane / orientation detection [14], [15], and echocardiographic
video classification tasks [16]. Given this success, there is
clear need to explore/develop interpretable frameworks that
are compatible with deep learning models.
Interpreting deep learning models remains complicated.
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Fig. 1: General framework for multimodal risk assessment. EHR data and cardiac ultrasound videos are input to the risk
assessment system. We emphasize the use of separable non-linear models where we look at contributions from each modality
and each feature separately and also within the joint multimodal framework. The mortality risk assessment is used to inform
treatment.
Nevertheless, significant progress has been made as docu-
mented in section VI of [11]. There, the authors list well
accepted methods such as maximum activation, imposing con-
straints, qualitative clustering, and a mimic learning method
that approaches deep learning performance using a gradient
boosting tree. Unfortunately, maximum activation is imprac-
tical for global interpretations since there is a very large
number of internal neurons that can be maximized. Imposing
constraints can limit the search space and help interpretability.
As we shall see, we will also impose non-negativity constraints
to resolve ambiguities. For image analysis applications, two
additional approaches to support interpretability have been
introduced. First, for convolutional neural network (CNN)
based methods, we can look at the output images from each
pool layer to understand how the CNN performs feature
extraction at different levels. Second, more recently, there is
an effort to support interpretability by using CNNs to perform
semantic segmentation. The basic approach described in Fully
Convolutional Networks (FCN) [17], SegNet [18], and U-
net [19], is to use an auto-encoding structure that predicts
class labels of each pixel by using a transposed version
of a traditional CNN architecture. Yet, large scale semantic
labeling of big datasets, such as those available in the EHR,
is intractable.
Clinical interpretation of the importance of deep learning
features is considerably more challenging. Early efforts to
provide feature importance have been reported by Gevrey et.
al in [20]. In classical stepwise selection, feature importance is
assessed based on performance changes. More directly, we can
use the partial derivative of the output with respect to a specific
input feature to assess their linear dependency. In this case, a
positive partial derivative implies that an increase in the input
feature value will also result in an increase in the output. On
the other hand, a negative partial derivative indicates that an
increase in the feature will result in a reduction of the output.
More recently, Ribiero et al. [21] proposed feature ranking by
learning a Local Interpretable Model (LIME) that is agnostic to
the classifier. Depending on the underlying classifier, examples
of a local interpretable model include a linear model or a
single decision tree that capture the behavior of the classifier
for small variations of the input.
Both the partial derivative and the LIME approaches cannot
provide global descriptions of the input effects. To understand
this problem, we note that local linear models can vary
significantly from sample to sample. Hence, when using LIME
or partial derivatives, there is a need to specify all of the
inputs and then fit the local linear model to the specific patient.
Estimating global trends is therefore impossible. As a result,
it is not clear how to model the effects of what happens
when there are dramatic changes due to effective treatment
or substantial changes in lifestyle.
To support the development of clinically interpretable mod-
els, we propose a deep learning architecture comprising sep-
arable models. Our basic approach is to consider polynomial
transformations of each scalar input factor separately and then
use a simple weighted sum to combine their contributions—
along with other inputs, including video, binary, or continuous
variables—for predicting mortality risk. This approach has
several advantages. First, we can use the weights to assess
the importance of each scalar factor. Second, we can provide
a global assessment of the contribution of each scalar factor
by simply zeroing out the weights of the remaining factors. In
other words, by using separable models, global effects can be
modeled for each scalar factor independently.
Here, we demonstrate the value of this approach by applying
it to several different types of multi-modal input datasets
with the goal of predicting the risk of 1-year mortality after
echocardiography. We utilize three different sets of input
variables: (i) clinical data (CD) only (e.g. age, sex, diagnoses
and laboratory values) (ii) numeric variables derived from
echocardiography videos, which we call echocardiography-
derived measures (EDM), and (iii) CD+EDM+raw videos
(pixel data from the parasternal long axis view), as described
in [16]. By considering models that utilize different variable
inputs, we can investigate the contributions of each modality
separately. For example, by comparing predictions derived
using EDM only against the results from video analysis, we
establish that EDM are just as effective for risk assessment
(we note that this utilized only a single video out of more
than 30 that are typically acquired during an echocardiogram
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Fig. 2: Architecture of the proposed multi-modal system.
The top portion shows the video analysis system and how it
produces a scalar output that is input to the sigmoid activation
function. The bottom part shows the nonlinear, separable
model where the EHR factors are transformed by polynomials
and input to the same sigmoid.
and used to derive the “EDM” inputs). On the other hand,
we also establish that risk assessment based on multiple
modalities significantly outperforms predictions based on any
single modality. Furthermore, multimodality feature ranking
provides a quantitative assessment of how features from each
modality contribute to optimal risk assessment.
The remainder of the paper is organized into four additional
sections. In section II, we describe the proposed methodology
while in section III we describe the dataset. We then provide
results and discussion in section IV and concluding remarks
in section V.
II. METHODS
We present the overall architecture in Fig. 2. The multi-
modal data are broken into the Echocardiography videos from
the parasternal long axis view; 100 scalar clinical variables
including 90 cardiovascular-relevant ICD-10 codes, age, sex,
height, weight, heart rate, blood pressures, LDL, HDL, and
smoking status; and 49 echocardiography derived measure-
ments (EDM), which are numbers measured from the image
data by clinicians or technologists. We refer to the supple-
mental material of [1] for a detailed description of the input
variables. We process the data to produce a risk score that
represents the likelihood of mortality within a year of the
echocardiogram.
The Echocardiography video is separated into individual
2D image frames where each frame is input to a CNN
with their outputs input to LSTM cells to capture temporal
dependencies across the frames. To support consistency in the
learned parameters, the video represents approximately two
cycles (exactly 2 seconds) of the heart beat acquired at the
parasternal long axis view, sampled at 30 frames per second
at a resolution of 109×150 pixels, and starting at the peak
of the R-wave of the electrocardiographic QRS complex. The
parasternal view contains elements of the left ventricle, left
atrium, right ventricle, aortic and mitral valves within a single
view. This view also potentially includes pericardial or left
pleural effusion, and is thus a highly informative video that is
typically the first acquired during a clinical echocardiogram.
We provide a detailed description of the video analysis system
in section II-A.
At the top level, we combine the results from the different
subsystems to produce a single score. For the EHR variables,
we use separable, polynomial transformations to transform
each continuous or categorical variable independently. We
provide a detailed description of the transformations and the
different models in section II-B.
In subsection II-C, we interpret the proposed methodology
for ranking feature by risk association. We carefully describe
how we train, test, and validate the models in II-D. We will
later demonstrate our recommendations for interpreting the
variables in section IV.
A. Video risk model
We describe the proposed architecture in Table I and Fig.
2. Alternative designs were also considered as described in
the ArXiv document given in [16]. The chosen architecture
gave optimal results when tested for four different image
resolutions, the addition of optical flow feature maps, and for
alternative echocardiographic image planes/views other than
the parasternal long axis view [16].
The input consists of a video with 60 image frames with
109×150 pixels per image. Each video frame was processed
through the CNN architecture shown in the middle of Fig.
2. The CNN consists of four ConvNet layers (L1 to L4).
Within each ConvNet, we have two convolution sub-layers
with rectified linear unit (ReLU) activations. Thus, Conv1
takes a single frame as an input and produces four feature
maps. Then, each Conv1 feature map is further processed by
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TABLE I: CNN architecture with 4,237 trainable and 56 non-
trainable parameters. Refer to Fig. 2 for the dimensions of
the convolution layers. L1, L2, L3, and L4 refer to the four
convolution layers shown in the middle diagram of Fig. 2.
Each CNN has a single image frame of 109×150 pixels as
input. All convolution layers use 3x3 kernels. We use the term
“group of feature maps” to refer to the collections of feature
maps shown in Fig. 2.
Layer # Parameters Description
Input - 60x109x150 gray scale video
L1: Conv1+ReLU 40 4 2D feature maps
L1: Conv2+ReLU 148 4 groups of feature maps
L1: Batch norm. 16 Normalize feature map groups
L1: Max Pool - 3x3 max-pooling
L2: Conv3+ReLU 296 8 groups of feature maps
L2: Conv4+ReLU 584 8 groups of feature maps
L2: Batch norm. 32
L2: Max Pool - 3x3 max-pooling
L3: Conv5+ReLU 584 8 groups of feature maps
L3: Conv6+ReLU 584 8 groups of feature maps
L3: Batch norm. 32
L3: Max Pool - 3x3 max-pooling
L4: Conv7+ReLU 584 8 groups of feature maps
L4: Conv8+ReLU 584 8 groups of feature maps
L4: Batch norm. 32
L4: Max Pool - 3x3 max-pooling
LSTM 544 8 hidden units
LSTM 208 4 hidden units
Dense+ReLU 20 4 hidden units
Output+Sigmoid 5 1 output unit
four Conv2 filters to produce a 4×109×150 feature map (see
Fig. 2). We normalize each feature map group with a batch
normalization layer. For batch normalization, we have two
learnable parameters (β ,γ), and two non-learnable parameters
(µ,σ ) that are computed during runtime as given in [22]. Thus,
we have 4×4= 16 parameters for Batch normalization for L1.
The feature maps are then passed through a Max pool layer
applied to each image to reduce the resolution of each by a
factor of 3. Similar connections apply for L2, L3, and L4 as
shown in Fig. 2 and Table I. The CNN output for each frame
is 8 feature maps.
We use two LSTM layers to process the CNN outputs.
The CNN outputs from each frame form a time-sequence
input to an LSTM layer with 8 hidden units. Then the output
of this LSTM layer is input to another LSTM layer with 4
hidden units. The final output is a 4-dimensional vector that is
processed through a fully connected layer to a single sigmoid
activation (see Table I).
B. Multi-modal Models for Mortality Risk Prediction
In order to integrate clinical features from multiple modal-
ities, we differentiate between categorical factors (e.g., sex),
continuous clinical factors (e.g., age), and a video risk factor.
Here, we emphasize the special importance of clinical factors
that have played a traditional role in diagnosis as opposed to a
video risk factor that does not have a clear and well understood
clinical interpretation within the context of a risk model.
Furthermore, to assess the effects of the different modalities,
we construct models based on three different sets of variables.
First, we consider single modality models based on: (i) CD
only (ii) EDM only, and (iii) an echocardiography video from
parasternal long axis view, which does not include any other
measurements. Second, we consider a hierarchy of multimodal
models starting from CD data without EDM, adding EDM, and
then adding the results from video analysis as well.
We begin by defining all of the variables. Let the list
of r scalar clinical factors that exclude EDM be given by
Xs = [x1,x2, . . . ,xr]T and let ms(Xs) denote the single modality
model based on them. Similarly, let the EDM variables be
given by: Xv = [xr+1,xr+2, . . . ,xr+v] with mv(Xv) as the corre-
sponding model. For the video analysis system, let V denote
the input video and let mV (V ) denote the video analysis system
described in section II-A.
We consider polynomial transformations applied to
each scalar factor separately as given by: P(Xs) =
[p1(x1), p2(x2), . . . , pr(xr)]T and similarly for P(Xv). We use
a weighted sum of the contributions from each polynomial
based on:
W Ts P(Xs) = w1 p1(x1)+w2 p2(x2)+ · · ·+wr pr(xr) (1)
that satisfy
Ws = [w1,w2, . . . ,wr],∀wi ≥ 0, (2)
and similarly for W Tv Xv. Here, we require positive weights
to eliminate any model ambiguities since wi pi(xi) and
−wi(−pi(xi)) represent the same term. For binary variables,
we simplify W Tb Pb(Xb) =W
T
b Xb and remove the non-negative
constraint for Wb.
For each modality, we consider a sigmoid for modeling the
risk likelihood. We thus have that the CD scalar and EDM
models are given by:
ms(Xs) = σ(W Ts P(Xs)+bs) (3)
mv(Xv) = σ(W Tv P(Xv)+bv) (4)
where bs,bv represent bias terms, and σ(.) represents the
sigmoid function. We use a binary cross-entropy cost function
to train the different models and learn the polynomial weights,
coefficient weights, and bias terms.
For the hierarchical, multi-modality models, we consider
the original scalar model (ms(Xs)), a second model that also
considers EDM: msv(.), and the full multi-modality model:
msV (.). To simplify the notation, we use the same weight
variables to define msv(.) and msV (.) as given by:
msv(Xs,Xv) = σ(W Ts P(Xs)+W
T
v P(Xv)+bsv) (5)
msV (Xs,Xv,V ) = σ(W Ts P(Xs)+W
T
v P(Xv)+w
T
VV +bsV ) (6)
where bsv,bsV represent bias terms, and the weights Ws,Wv,wV
will need to be learned for the new models.
C. Interpretable Models
We provide interpretation of the proposed methodology
based on separability that allows comparisons among the
multi-modal input features, whether scalar, binary or video.
We begin with interpreting the contributions of scalar features.
We then proceed with looking at the relative importance of the
different features within the different models.
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Each scalar feature contributes to the overall mortality risk
through its corresponding coefficient weight that is then input
to a logistic regression layer,
ms(Xs) =
1
1+ exp(−W Ts (P(Xs)+bs))
(7)
that gives a risk score. Since we are using the logistic regres-
sion σ(.), from σ(logit(pmort)) = pmort, where pmort represents
the event probability, we have:
W Ts P(Xs)+bs = logit(pmort)
= log
(
pmort
1− pmort
)
(8)
where pmort/(1− pmort) represents the odds ratio for the event.
We say that the product W Ts P(Xs)+bs represents the log-odds
of a mortality event [23]. To understand the risk contribution
for the i-th feature, we exponentiate both sides of eq. (8) to
eventually derive:
Odds-ratio =C · exp(wi pi(xi)) (9)
where C represents contributions from the rest of the features.
From eq. (9), we can see how the weight magnitude can be
used to quantify specific feature contributions to the odds ratio.
We will refer to eq. (9) in the results.
We rank the importance of each feature by simply ranking
the corresponding weights: w(1) ≥ w(2) ≥ ·· · ≥ 0. Here, it is
important to note that eq. (9) describes the contribution of each
factor over the entire range of possible values. In other words,
it is not a local model that is specific to small changes of a
given patient. Instead, large-scale changes can be described
by looking at the change from exp(wi pi(xi)) to exp(wi pi(xi+
∆xi)) where ∆xi is used to describe a large change in xi.
To understand the contributions from the video measure-
ments, we rely on the joint interpretation of our hierarchical
models: ms(.),msv(.),msV (.). As long as the different models
contribute information associated with the label, we expect
the performance to follow the hierarchy with msV (.) giving
the best results, followed by msv(.), and then either of ms(.),
mv(.), or mV (.). The relative improvement in performance can
be attributed to the added information in each model. Thus,
the performance improvement of msv(.) over ms(.) is directly
attributed to the inclusion of EDM. Similarly, a performance
improvement of msV (.) over msv(.) implies that the video anal-
ysis system is extracting important features that are currently
not fully described by the EDM included in msv(.). Here, we
note that a substantial improvement of msV (.) over msv(.) may
imply that the current clinical EDM are incomplete. On the
other hand, the lack of a substantial improvement may be
due to the fact that the video processing system was unable
to provide new information that could surpass the standard
EDM that we are already making, on the context of one-year
mortality prediction. Moreover, potential lack of improvement
in this scenario could also be due to the fact that we are only
including one video out of an average of 20-40 videos acquired
per clinical echocardiogram due to computational limitations.
Beyond performance improvements, we look at changes
in weights and weight rankings to assess the importance of
each feature from each modality. Performance changes reflect
contributions from each modality as a whole, while weight
rankings reflect the relative importance of each feature against
all others. The presence of high-ranking features from all
modalities implies that each modality is making a significant
contribution. Further, the relative rankings also matter. For
example, the presence of video that ranks higher than echocar-
diography measurements implies that the video score contains
information already given by EDM but within a simpler, single
number. Similarly, weight rank changes between models can
offer strong clues about the inter-relationships between clinical
factors and different modalities.
We also compare our separable non-linear models against
generalized linear models (logistic regression models) and
non-separable non-linear models such as Random Forest [24]
and its extension in XGBoost [25]. Clearly, to justify the use
of non-linear models, we expect our models to perform better
than the generalized linear model. Then, we expect to be
able to provide clinical interpretability without a significant
sacrifice in performance. We refer to section IV to see that
this is indeed what we found.
D. Training, Validation, and Testing
To estimate the performance of the different models, we
performed 5 independent runs. For each run, the dataset was
broken into a training set, a validation set, and the test set.
We train over the training and validation sets. We report the
results over the 5 test sets.
For each run, we used 80% of the dataset for training and
validation and the remaining 20% for testing. Within the 80%
reserved for training and validation, we used 10% (8% of the
original dataset) for validation and the rest for fitting. The
training and test sets had the same prevalence of dead vs alive
(see Table II of section III). For the validation set, we used a
balanced proportion of 50% for each class of Table II.
We normalize each feature by mapping its minimum value
to -1 and the maximum value to +1 on the training set using:
xi,nor = 2 · (xi−min(xi))
(max(xi)−min(xi)) −1 (10)
Then, we apply eq. (10) to the validation and test sets with
the minimum and maximum values found on the training set.
To account for sample imbalance, we weigh the error
contributions based on the number of samples in each class
and average them. Thus, for the test error, we have 50% of
the error from each class of Table II.
Over the training set, we use the RMSProp optimization
method [26] to minimize the binary cross-entropy loss. We
trained for a maximum of 200 epochs with early stopping
if there was no reduction in the validation set loss over 10
consecutive epochs. We implemented all the experiments in
Keras (version 2.2) using default parameters. All training was
performed on an NVIDIA DGX-1 platform with 8 V100 32GB
GPUs.
III. DATASET
This retrospective study was approved by the Geisinger
Institutional Review Board and performed with a waiver of
consent.
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TABLE II: Demographics table of 31,278 EHR samples.
Survival
< 1 year ≥ 1 year
Count 4,977 26,301
Male (%) 50 56
Smoker (%) 65 59
Age (years) 73 ± 13 63 ± 16
Heart Rate (bpm) 81 ± 16 73 ± 14
EF (%) 51 ± 14 55 ± 10
LDL (mg/dL) 85 ± 32 93 ± 32
Diastolic Press. (mm[Hg]) 66 ± 14 72 ± 13
Systolic Press. (mm[Hg]) 124 ± 23 131 ± 21
A. Electronic Health Records
At the time of the study, Geisinger’s echocardiography
database contained 594,862 studies from 272,280 unique pa-
tients performed over 19 years (February 1998 to September
2018). Each study included patient identifiers, date, and a
findings report. Geisinger’s Phenomics Initiative database has
modeled these study data into tabular format with 480 human-
derived echocardiography measurements.
We retrieved the closest (before or after) fasting LDL, HDL,
blood pressure, heart rate, and weight measurements that were
not taken at the time of the Echocardiography study within
a six-month window. When no measurement was available
in that time window, we set the variable as missing. ICD-
10 diagnostic codes were formatted as indicator variables that
were matched against the date of echocardiography.
All measurements were cleaned from physiologically out
of limit values, which may be caused by input errors. In
cases where no limits could be defined for a measurement,
we removed extreme outliers that met two rules: 1) Value
beyond the mean plus or minus three standard deviations and
2) Value below the 25th percentile minus 3 interquartile ranges
or above the 75th percentile plus 3 interquartile ranges. The
outlier values were set as missing.
To support our models, we also needed to deal with missing
values. We filled in the missing data with two steps. First,
we conducted a time interpolation to fill in missing measure-
ments using all available studies of an individual patient, i.e.,
missing values in between echocardiography sessions were
linearly interpolated if complete values were found in adjacent
echocardiograms acquired before and after the study with a
missing value. Then, we kept 115 out of the 480 measurements
because they were the most commonly measured with less
than 90% missing values. This enabled us to conduct a robust
Multiple Imputation by Chained Equations (MICE) [27].
After imputation of the continuous measurements, we im-
puted the missing diastolic function (which is either normal,
abnormal or graded from 1 to 3 in severity) assessment
by training a logistic regression classifier (One-vs-All) using
278,160 studies where diastolic function was known. We
coded the reported diastolic function in an ordinal fashion
with -1 for normal, 0 for dysfunction (but no grade reported),
and 1, 2 and 3 for diastolic dysfunction grades I, II, and
III, respectively. We calculated the patient’s age and survival
time from the date of the echocardiogram. The patient status
(dead/alive) was based on the last known living encounter
or confirmed death date, which is regularly checked against
national death index databases in our system.
B. Echocardiography videos
An Echocardiography study consists of typically 20–40
ultrasound videos containing multiple views of the heart and
vessels with different orientations. We refer to [16] for details
in the video extraction and view labeling procedure.
From the echocardiography exams, we kept only the
parasternal long axis view since 1) this view is regarded
as the most useful view by cardiologists due to being able
to capture a large part of the heart’s anatomy in a single
view, 2) in our earlier investigations, this view gave the best
performance for predicting the risk of one-year mortality [16],
and 3) including additional videos remained computationally
challenging because of the ratio of available samples vs
number of parameters to train.
We linearly interpolated all raw videos to a time resolution
of 30 frames per second. We then cropped/padded each video
to 60 frames (2 seconds).
C. Clinical and Video Data Merge
We linked the clinical data (CD) and imaging data, and
discarded any unlinked data. We gathered 31,278 videos from
26,793 patients. The CD variables were age, smoking status
(ever smoked), sex, diastolic pressure, systolic pressure, heart
rate, height, weight, low-density lipoprotein (LDL), and high-
density lipoprotein (HDL). Finally, we removed studies with
less than 1 year of follow-up. Refer to Table II for a summary
of the merged dataset.
IV. RESULTS AND DISCUSSION
We begin with a discussion of the most significant features
in section IV-A. We then proceed with a discussion of risk
models for individual features in section IV-B, and a compar-
ison of the different models in section IV-C.
A. Significant features
We summarize the results for the most significant fea-
tures for the different models in Table III. As expected for
a survival model, age dominates all other features in the
basic CD model. Age still dominates even after considering
measurements derived from the videos (CD+EDM). Yet, heart
rate dominates age in the full model, while it remains the
second most important clinical factor in the basic CD and
CD+EDM models. Weight, diastolic pressure, and systolic
pressure complete the top 5 clinical factors that produced the
highest prediction weights. These clinical features are well
known and strongly support the interpretability of our results.
Without looking at the video, from the echocardiography
measurements (EDM), the Tricuspid Regurgitation Maximum
Velocity (TRMV) was the most significant measurement. In
fact, the TRMV replaced the systolic pressure from the list
of the top 5 clinical features in the combined CD+EDM
model. Here, in terms of contributions to the mortality risk,
we note that the TRMV measures the maximum velocity of
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(a) (b) (c) (d) (e)
Fig. 3: Example of low-level features extracted from the parasternal long axis view. In this example, we show the outputs
from the four feature maps produced by Conv1. The feature maps represent outputs produced using 3x3 kernels and ReLU
activation functions. (a) Original image. (b) First feature map, enhanced with a dilation operation for illustration purposes. (c)
Second feature map. (d) Third feature map. (e) Fourth feature map.
blood flowing backwards from the right ventricle into the
right atrium, which is an indirect measure of pulmonary artery
systolic pressure and thus a marker of pulmonary hypertension.
Pulmonary hypertension is highly correlated to mortality, as
previously discussed in detail in [1], and thus this further
supports clinical interpretability of the model.
For the combined model, the video analysis system was the
most significant feature. Unfortunately, it is difficult to provide
a clinical interpretation of exactly what is being measured by
the video analysis system. At the lower layers, we do expect
the video analysis system to extract low level features. In our
analysis of video outputs from the lower levels, we have found
that lower layers do extract cardiac wall features. To show this,
we present sample results from the first four features maps
generated by Conv1 in 3. The output images from Figs 3(b)-(e)
vary significantly. Yet, in Fig. 3(b), we can see the extraction
of specific bright points over the aortic valve (center), as well
as irrelevant artifacts from the periphery of the scan. We expect
that the irrelevant artifacts from the periphery will be rejected
by higher layers. In Fig. 3(c), we can see that the cardiac walls
are enhanced while the background is suppressed. Cardiac wall
enhancement is less pronounced in Fig. 3(d). On the other
hand, Fig. 3(e) looks very similar to the input. Hence, it is clear
that interesting features from Fig. 3(e) can only be extracted
at higher layers.
TABLE III: Feature importance based on the largest weights
extracted for the different models. The weights represent
averages over 5 runs. LVIDd refers to the left ventricular
internal diastolic dimension. AI dec slope refers to the aortic
insufficiency deceleration slope.
CD EDM CD+ Video+
(no EDM EDM CD+
or Video) (no Video) EDM
PL view video - - - 3.86
Heart Rate 2.63 - 1.91 1.72
Age 3.40 - 2.84 1.36
Tricuspid RMV - 1.80 1.58 1.09
Diastolic Pressure 1.63 - 1.40 0.96
AI dec slope - 1.20 - -
Ejection Fraction - 1.82 - -
End Systolic Vol - 1.45 - -
LVIDd - 1.43 - -
Systolic Pressure 1.38 - - -
Weight 1.64 - 1.93 -
B. Risk model assessment for individual features
We present risk models for the most relevant clinical fea-
tures for the full model in Fig. 4. Our risk models include
the most significant features discussed in section IV-A as
well as some measures that are routinely used in clinical
diagnosis and prognosis. Since we are using the full model,
it is important to note that our separable interpretations will
have to be combined together for the final risk assessment.
We begin with the age factor as a predictor in the CD+EDM
model (see Fig. 4(a)). It is clear that mortality increases with
age as evidenced by the histogram differences between the
two populations (survivors versus non-survivors). In fact, with
a weight coefficient of 2.84 (see Table III), we have a 17-
fold increase in the odds ratio (probability of dying within a
year), when going from an age of 18 to 110. The risk function
appears to follow a near linear trend from 40 to 80.
Increased heart rates lead to significant risk increases as
shown in Fig. 4(d). Since these measurements are taken
from patients at rest, a low resting heart rate may indicate
a physically active and therefore generally healthier person,
whereas a high rate may be a marker of arrhythmias and/or
heart failure.
Extreme low weight gave the highest risk in Fig. 4(e). From
low to average weight, we observe that the risk also drops
sharply. The risk drops to the lowest value for obese patients.
The trend from average to high weight, while appearing to
be counter-intuitive, is compatible with the “obesity paradox”
noted in multiple prior studies (see [28]). An additional
possible explanation is that low weight is a high risk factor
TABLE IV: Multi-modal model performance. For each method
and data combination, we present the average AUC and
standard deviation based on 5 independent runs. IMNN (Inter-
pretable Multimodal Neural Network) refers to the proposed
method. The CD model does not include EDM or Video
features. All 3 refers to Video+CD+EDM.
Model IMNN Logistic Random XGBoost
Input (proposed) Regression Forest
CD 0.78 (0.01) 0.79 (0.01) 0.81 (0.00) 0.81 (0.01)
EDM 0.76 (0.01) 0.74 (0.02) 0.77 (0.01) 0.77 (0.01)
Video 0.73 (0.02) - - -
CD+EDM 0.82 (0.01) 0.81 (0.01) 0.81 (0.01) 0.82 (0.01)
All 3 0.82 (0.01) - - -
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Fig. 4: Full model risk functions (blue) with normalized histograms of survivors (light green) and non-survivors (red orange).
When the two histograms overlap, the histograms appear light brown. (a) Age risk plots. (b) Tricuspid regurgitation maximum
velocity (TRMV) plots. TRMV is measured in cm/s. (c) physician reported left ventricular ejection fraction in %, (d) heart rate
in beats per minute, (e) weight in kilograms, (f) aortic insufficiency deceleration slope (AI dec slope) in cm/s2, (g) diastolic
and (h) systolic blood pressure in mm Hg, (i) left ventricular internal dimension at end-diastole in cm, and (j) left ventricular
end systolic volume in ml. The uncertainty in the risk functions are derived from the 5 results across the 5 runs.
for short term (<1 year) mortality and high weight may have
a higher association with longer term mortality.
We have decreasing risk trends for larger values of systolic
and diastolic pressure (see Figs. 4(g)-(h)). Though lower blood
pressure being associated with higher risk is counterintuitive,
two explanations are plausible. First, a high blood pressure
does not lead to 1-year mortality but rather leads to longterm
cumulative effects such as renal and heart failure that result in
longer-term increased mortality. Second, low blood pressure
may be a marker of cardiac decompensation. Full understand-
ing of this trend will require further study and also accounting
for many medications known to affect blood pressure.
We have a strong, increasing trend for increases in the
tricuspid regurgitation maximum velocity (TRMV, see Fig.
4(b)). Based on our prior discussion on the TRMV, this trend
is clearly to be expected and compatible with pulmonary
hypertension being strongly linked to mortality.
From Fig. 4(f), we can see that higher values of the aortic
insufficiency deceleration slope demonstrate the relationship
between severity of aortic valve regurgitation/insufficiency
and mortality [29]. On the other hand, from Fig. 4(i), we
see a counter-intuitive trend for the left ventricular internal
dimension that suggests a lower value is associated with a
higher risk of death, which is opposite of what is expected
[30]. However, the histograms in Fig. 4(i) show little difference
between the surviving and non-surviving populations. Hence,
it is not a surprise that this feature was not found to be
significant and the trend likely is spurious. From Fig. 4(j), we
observe that the left ventricular end systolic volume, which
is a better marker of ventricular size than the LV internal
dimension described above, follows the expected trend of
worsening mortality for higher values.
A mixed trend is observed for the left ventricular ejection
fraction (EF) in Fig. 4(c). Here, we note that the EF is the
percentage of blood that leaves the heart chambers during
contraction. From a minimum risk at 65%, the odds ratio
indicates a two-fold increase in risk at an EF of 10% or lower,
and a 56% risk increase for an EF of 85% or higher. For low
risk cases, the EF risk function agrees with standard clinical
interpretation and the current American Heart Association
guidelines (reviewed as of May 31, 2017) for a normal EF,
which is between 50% and 70%. Increased risk with high
EF may be a marker of a hyperdynamic heart failure with
preserved ejection fraction or additional pathologic factors
known to elevate EF such as mitral regurgitation or concentric
hypertrophic remodeling (either genetic or acquired secondary
to hypertension).
C. Model results
Our model results are summarized in Table IV. First, we
note that the performance of the CD+EDM with Random
Forest model does not match the performance reported in [1]
(0.81 vs 0.84 AUC). We determined that the source of this
difference relates to the specific subset of patients included
in this analysis (selected based on the availability of the
raw echocardiography videos). While the exact cause of the
bias is unknown, we do note that our current population,
compared to that of [1], did exhibit several demonstrable
differences in features, such as 1) increased prevalence of dead
patients within a year (16% vs 12%); 2) larger proportion
of patients with mild Tricuspid (33% vs 26%) and Mitral
(33% vs 25%) Regurgitation; and 3) larger percentages of
patients with diagnoses of chronic kidney disease (19% vs
13%), hypertension (54% vs 47%) and heart failure (16% vs
13%).
Even with our limited statistics from 5 independent runs,
we conducted 5 paired t-tests with α = 0.01/5 to test for
AUC average differences among modalities (CD vs EDM,
CD vs Video) and the use of additional modalities (CD
vs CD+EDM, CD+EDM vs CD+EDM+Video (“All”)). We
found no significant differences among the different single
modalities. Yet, we found a significant increase in the AUC
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when multiple modalities were utilized. In particular, we found
a significant increase from CD (AUC average = 0.78) to
CD+EDM (AUC average = 0.82). On the other hand, we
did not find significant differences between the CD+EDM
model and the CD+EDM+Video model. Future work can likely
improve upon this by adding more computational complexity
with the addition of many more echocardiographic views to
the models, which will likely result in improved accuracy
with appropriate increases in sample size to balance additional
parameters that need to be trained. In addition, we acknowl-
edge that the interaction between variables is not addressed by
the proposed model and that the separable approach assumes
independent features. However, this work can be extended to
cover conditional transformations (e.g., see [31]) or include the
multiplication of factors as in traditional general linear models
analysis to account for interactions in future work.
Overall, the full multi-modal model performed as well as
any other model. For CD+EDM, most models performed as
well as the full model. However, it is important to note that the
complex non-linear relationships of Fig. 4 are only possible
through using our interpretable model. Logistic regression only
allows linear models, which are clearly inadequate for many
clinical features (see Fig. 4). On the other hand, while we
can also assess feature importance with Random Forest and
XGBoost, there is no clear understanding of what any single
feature contributes to the risk as has been demonstrated with
the newly proposed interpretable model.
V. CONCLUSION
This paper introduces interpretable models for risk assess-
ment in clinical scenarios that demand multi-modal data in-
puts. Through the use of separable, non-linear models, we are
able to quantify the contributions of individual clinical factors
to the overall risk, assuming the remaining factors remain
constant. The approach allows us to visualize complex non-
linear relationships between changes in each factor and other
non-linear models. Overall, the proposed interpretable models
matched the performance of more complex non-linear methods
and thus demonstrate significant potential for expanding the
use of neural networks in medicine.
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